Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nils Kronas
Inhaled and Intravenous Application of a Stimulator of the Soluble Guanylate Cyclase (BAY 41-8543) Reduces Pulmonary Vascular Resistance in a Model of Septic Shock
BMC Pharmacology
Related publications
BAY 63–2521, an Oral Soluble Guanylate Cyclase Stimulator, Has a Favourable Safety Profile and Decreases Peripheral Vascular Resistance in Healthy Male Volunteers
BMC Pharmacology
Effects of Age and Sex on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521)
Pulmonary Circulation
Pulmonary
Respiratory Medicine
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
PLoS ONE
Multidisciplinary
The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats
BMC Pharmacology
EXPRESS: First-In-Child Use of the Oral Soluble Guanylate Cyclase Stimulator Riociguat in Pulmonary Arterial Hypertension
Pulmonary Circulation
Pulmonary
Respiratory Medicine
The Effects of the Soluble Guanylate Cyclase Stimulator Riociguat on Memory Performance in Healthy Volunteers With a Biperiden-Induced Memory Impairment
Psychopharmacology
Pharmacology
Molecular Steps in Soluble Guanylate Cyclase Activation
BMC Pharmacology
A Nitric Oxide/Cysteine Interaction Mediates the Activation of Soluble Guanylate Cyclase
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Soluble Guanylate Cyclase Stimulators and Phosphodiesterase-5 Inhibitors in Therapy of Some Groups of Pulmonary Hypertension
Pulmonologiya
Pulmonary
Respiratory Medicine
